Liver transplantation and surgery: Alea iacta est
Michael F. Sorrell, Byers W. Shaw – 1 January 1995
Liver transplantation for chronic viral hepatitis
Teresa L. Wright, Brian Pereira – 1 January 1995
Editorial comment
Byers W. Shaw – 1 January 1995
Microchimerism in organ transplantation
Nancy L. Ascher – 1 January 1995
A unos perspective on donor liver allocation
R. Randal Bollinger – 1 January 1995
Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B
Fritz Von Weizsäcker, Irmgard Pult, Katja Geiss, Stefan Wirth, Hubert E. Blum – 1 January 1995 – Hepatitis B virus (HBV) nucleotide sequences isolated from mother/child pairs were analyzed in three cases of neonatal fulminant hepatitis B (FHB). Heterogeneous HBV sequences consistent with both adw2 and ayw subtype were found in all three mothers. In one case, in which the child survived, both subtypes were transmited. By contrast, only the ayw subtype was present in the two other children with a fatal course of FHB.
Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection
Rosendo Jardi, Maria Buti, Montserrat Cotrina, Francisco Rodriguez, Helena Allende, Rafael Esteban, Jaime Guardia – 1 January 1995 – The objective of this study was to evaluate the usefulness of hepatitis delta virus (HDV) RNA detection by polymerase chain reaction (PCR) in acute and chronic D hepatitis and to correlate with HDV‐RNA detection by dot blot and hepatic delta antigen.
Hepatic collagen synthesis and degradation during liver regeneration after partial hepatectomy
Hiroko Yamamoto, Yoshikazu Murawaki, Hironaka Kawasaki – 1 January 1995 – To elucidate hepatic collagen metabolism during liver regeneration after partial hepatectomy, we measured collagen content, collagen synthesis, and collagen‐degrading enzyme activity in the remnant livers of rats 3, 5, 7, and 14 days after a partial hepatectomy of 68%.
Fulminant hepatic failure: Summary of a workshop
Jay H. Hoofnagle, Robert L. Carithers, Craig Shapiro, Nancy Ascher – 1 January 1995 – Fulminant hepatic failure (FHF) is defined by the appearance of severe liver injury with hepatic encephalopathy in a previously healthy person. There are an estimated 2,000 cases of FHF in the United States yearly, representing 0.1% of all deaths and, perhaps, 6% of liverrelated deaths. The causes of FHF are many, the chief ones in the United States being hepatitis A; B; non‐A, non‐B and drug induced liver disease.